Iridium containing hydrosilylation catalysts and compositions containing the catalysts
US-9221041-B2 · Dec 29, 2015 · US
US9637503B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9637503-B2 |
| Application number | US-201615186823-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 20, 2016 |
| Priority date | Aug 7, 2012 |
| Publication date | May 2, 2017 |
| Grant date | May 2, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The method relates to the field of asymmetric allylic amination and comprises preparing a chiral N-substituted allylic amine compound from the corresponding allylic substrates and substituted hydroxylamines, in the presence of a catalyst, said catalyst comprising copper compounds and a chiral ligand. Examples of chiral amine compounds which can be made using the method include Vigabatrin, Ezetimibe Terbinafine, Naftifine 3-methylmorphine, Sertraline, Cinacalcet, Mefloquine hydrochloride, and Rivastigmine. There are over 20,000 known bioactive molecules with chiral N-substituted allylic amine substructure. The method may also be used to produce non-natural chiral β-aminoacid esters, a sub-class of chiral N-substituted allylic amine compounds. Examples of β-aminoacid ester which can be produced by the disclosed method, include, but are not limited to, N-(2-methylpent-1-en-3-yl)benzenamine and Ethyl 2-methylene-3-(phenylamino)butanoate. Further, the products of the method described herein can be used to produce chiral heterocycles and bioactive molecules or materials. A novel chiral copper-BINAM nitrosoarene complex is also set forth.
Opening claim text (preview).
The invention claimed is: 1. A chemical compound having the formula [Cu(BINAM) 2 (ArNO) 2 ]OTf 2 . 2. The chemical compound of claim 1 wherein the compound is a chiral copper-BINAM nitrosoarene complex. 3. A chemical compound comprising: a. a copper atom; b. two nitrosoarenes; c. two BINAM ligands; d. two triflates. 4. The chemical compound of claim 3 wherein the compound is a chiral copper-BINAM-nitrosoarene complex. 5. The chemical compound of claim 3 wherein the copper-nitroso complex is chiral. 6. The chemical compound of claim 3 wherein at least one ligand is chiral. 7. The chemical compound synthesized from the process of combining copper triflate (Cu(OTf) 2 ), and R(+)-BINAM in the presence of toluene. 8. The chemical compound of claim 7 wherein the process comprises the steps of first creating a mixture of Cu(OTf) 2 , R(+)-BINAM, and toluene, stirring the mixture, and removing the solvent once a desired chemical compound is produced.
without C-Metal linkages · CPC title
by substitution of hydrogen atoms by amino groups · CPC title
by stereospecific synthesis · CPC title
from amines, by reactions not involving amino groups, e.g. reduction of unsaturated amines, aromatisation, or substitution of the carbon skeleton · CPC title
Optical isomers · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.